Page last updated: 2024-08-23

amikacin and Blood Poisoning

amikacin has been researched along with Blood Poisoning in 204 studies

Research

Studies (204)

TimeframeStudies, this research(%)All Research%
pre-199090 (44.12)18.7374
1990's27 (13.24)18.2507
2000's32 (15.69)29.6817
2010's41 (20.10)24.3611
2020's14 (6.86)2.80

Authors

AuthorsStudies
Arabzadeh, AA; Khezrnia, SS; Mojtahedzadeh, M; Najafi, A; Najmeddin, F; Rouini, MR; Sefidani Forough, A; Shahrami, B1
Al-Faifi, J; Ibrahim, ME1
Assaly, R; Beran, A; Georgescu, C; Hochanadel, A; Luttmann, K; Mhanna, M; Srour, O1
Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y1
Assenga, EN; Godfrey, E; Majaliwa, E1
Ananthamurthy, K; Aranjani, J; Chaudhari, BB; Chaudhari, P; Ghate, V; Lewis, S; Maxwell, A; Moorkoth, S1
Chen, J; Liu, W; Zhao, F1
Bai, Y; Fan, X; Fu, L; Tian, C; Wang, S; Xing, M; Zhao, Y1
Cömert, B; Ergan, B; Ergün, B; Esenkaya, F; Gökmen, AN; Hanci, V; Heybeli, C; Küçük, M; Uzun, Ö; Yakar, MN1
Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y1
Ceballos, J; Cortínez, L; García, A; Ibacache, M; Inojosa, R; Leguizamon, L; Maccioni, A; Meza, S; Paredes, N; Paulos, C; Ramírez, M; Severino, N; Toso, A; Urzúa, S; Von Mentlen, C1
Bijleveld, YA; de Haan, TR; Mathôt, R; Samb, A; Sinkeler, F; van Kaam, A1
Cermanová, J; Chládek, J; Doleželová, E; Mičuda, S; Prašnická, A; Springer, D; Studená, Š1
Annaert, P; De Winter, S; Desmet, S; Dreesen, E; Meersseman, W; Peetermans, W; Spriet, I; Van den Eede, N; van Hest, R; Vanbrabant, P; Verelst, S; Wauters, J1
Allegaert, K; Cristea, S; Knibbe, CAJ; Krekels, EHJ; Kulo, A; Smits, A; van Weissenbruch, M1
Aliska, G; Azwar, MK; Dewi, TU; Karuniawati, A; Purwantyastuti, P; Sedono, R; Setiabudy, R1
Astroza, G; Catalán, M; Cerón, I1
Arrivé, L; Monnier-Cholley, L; Pacanowski, J; Roux, A1
Byrne, BA; Edman, JM; Kass, PH; Magdesian, KG; Theelen, MJP; Wilson, WD1
Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C1
Dhareshwar, J; Gulia, S; Gupta, S; Kannan, RA; Rodrigues, C; Vora, A1
Ahmadi, A; Mahmoudi, L; Mohammadpour, AH; Mojtahedzadeh, M; Niknam, R1
Dwijayanti, A; Louisa, M; Rundjan, L; Setiabudy, R; Simanjuntak, E; Suwento, R; Yasin, FH1
Fink, L; Gaylis, F1
Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S1
Duszynska, W; Hurkacz, M; Kowalska-Krochmal, B; Kübler, A; Taccone, FS; Wiela-Hojeńska, A1
Bethou, A; Biswal, N; Mathai, B; Ramasamy, S1
Samiee-Zafarghandy, S; van den Anker, JN1
Doluoglu, OG; Eroglu, M; Ozgur, BC; Sarici, H; Telli, O1
Jain, N; Tewari, VV1
Brodowska-Kania, D; Dubchak, I; Gomółka, M; Jurkiewicz, D; Niemczyk, S; Piechota, W; Rymarz, A; Szamotulska, K1
Bhat Y, R; Lewis, LE; Patra, S; Purakayastha, J; Sivaramaraju, VV1
Garg, A; Goel, A; Nangia, S; Randhawa, VS; Saili, A; Sharma, S1
Ahmadi, A; Ahmadvand, A; Khalili, H; Mahmoudi, L; Mojtahedzadeh, M; Najafi, A; Najmeddin, F; Sadeghi, K1
Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F1
Bursle, E; Cotta, MO; Gowen, B; Lipman, J; McWhinney, B; Roberts, JA; Truloff, N; Ungerer, JP1
Allegaert, K; Danhof, M; De Cock, RF; Knibbe, CA; Smits, A; Vanhaesebrouck, S1
Allaouchiche, B; Evrard, A; Friggeri, A; Knani, H; Lavigne, JP; Lefrant, JY; Louart, B; Muller, L; Nucci, B; Roberts, JA; Roger, C1
Dey, AC; Dey, SK; Hossain, MI; Mannan, MA; Shahidullah, M1
Broadbent, RS; Medlicott, NJ; Reith, DM; Sherwin, CM; Svahn, S; Van Der Linden, A2
Araoka, H; Baba, M; Matsuno, N; Takagi, S; Taniguchi, S; Tatsushima, K; Wake, A; Yoneyama, A1
Cunha, CL; Fadel, MV; Leão, MT; Repka, JC1
Estéves Jaramillo, A; Ortiz-Ibarra, FJ; Reyna-Figueroa, J1
Khan, DA; Khan, FA; Razzaq, A; Siddiqi, A1
Cumps, J; Delattre, IK; Dugernier, T; Jacobs, F; Laterre, PF; Musuamba, FT; Spapen, H; Taccone, FS; Verbeeck, RK; Vincent, JL; Wallemacq, PE; Wittebole, X1
Fagnoul, D; Jacobs, F; Layeux, B; Taccone, FS; Vincent, JL1
Delattre, IK; Jacobs, F; Laterre, PF; Musuamba, FT; Nyberg, J; Taccone, FS; Verbeeck, RK; Wallemacq, PE1
Abdel-Hady, E; Awad, H; El Hamamsy, M; Hedaya, M1
Çetinkaya, M; Köksal, N; Özkan, H; Sarısözen, B; Yazıcı, Z1
Castro, J; Cornejo, R; Gálvez, R; Illanes, V; Kosche, J; Llanos, O; Luengo, C; Romero, C; Tobar, E1
Eslamieh, H; Salamati, P; Taheri, PA1
Taccone, FS1
Aboussad, A; Chabaa, L; Elidrissi, NS; Issaoui, S; Maoulainine, FM; Sorra, N1
Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P1
Chaffanel-Peláez, M; Del Boz, J; Serrano-Martín, MM; Vera-Casaño, A1
Al-Maghrebi, M; Anim, JT; Kehinde, EO; Sheikh, M1
Fredrick, F; Massawe, A; Matee, MI; Mhada, TV1
Al Hammadi, AY; El Desoky, ES; Sheikh, AA1
Désinor, OY; Ménos, MJ; Silva, JL1
Ohyashiki, K1
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Mouktaroudi, M; Perrea, D1
Garg, RK; Marak, RS; Ray, P; Sharma, J; Sharma, M; Singhi, S; Taneja, N1
Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L1
Ferrer, NF; Hernández, ME; Ramos, MJ1
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T1
Bramhne, HG; Chhibber, S; Sharma, S; Toky, V1
Flidel-Rimon, O; Friedman, S; Leibovitz, E; Shinwell, ES1
Arch, J; González, QH; Hinojosa, C; Medina-Franco, H; Orozco, H; Pantoja, JP; Sifuentes-Osornio, J; Vargas-Vorackova, F; Vilatoba, M1
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M1
Magid, JH1
Alexandrou, I; Chrisofos, M; Geladopoulos, T; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karagianni, V; Koussoulas, V; Koutoukas, P; Kranidioti, H; Pelekanou, E; Sabracos, L; Tsaganos, T; Tzepi, I; Vassiliadis, J1
Chayani, N; Mahapatra, A; Mallick, B; Panda, R; Poddar, N; Roy, D; Sarangi, G1
Aguilar-Orozco, G; Del Carmen Ramos-Jiménez, A; Guadalupe Vásquez-Mendoza, M; Romero-Gutiérrez, G; Vargas-Origel, A1
Agrawal, C; Datta, V; Kumar, A; Mehta, G; Randhawa, VS; Saili, A1
Ahmed, IA; Ahmed, N; El-Beshlawy, A; El-Haddad, A; El-Mahallawy, HA; Nassif, S1
Rosoff, PM; Saini, S1
Guevara, A; Guevara, E; Guevara, M; Medina, L; Oliveros, M; Salomón, M1
Erdeljić, V; Francetić, I; Huić, M; Kalenić, S; Likić, R; Makar-Ausperger, K; Mercep, I; Simić, P; Tripković, V1
Brockmeier, D; Marget, W; Roos, R; von Hattingberg, HM1
Good, F; Harding, E; Klein, J; MacLeod, S; Perlman, M; Prober, CG; Rajchgot, P; Soldin, S1
Mirrett, S; Reimer, LG; Reller, LB1
Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D1
Lietman, PS; Moore, RD; Smith, CR2
Dupont, J; Fernández, A; Garay, G; López, H; Marcenac, F; Pavlovsky, S; Scaglione, C1
Cortelezzi, A; Penagini, R; Pogliani, EM; Radaelli, F1
Bock, BV; Edelstein, PH; Meyer, RD1
Brin, M; Donath, J; Kennish, A; Sanders, M; Wormser, GP1
de la Serna, JL; de Villota, ED; Diez-Balda, V; Galdos, P; Mosquera, JM; Rubio, JJ; Tomás, MI1
Cafarelli, A; Cruciani, M; Magliulo, E; Piantieri, G1
Yamaguchi, T1
Berk, SL; Gage, K; Ortega, G; Vracin, W1
Hindler, J; Martin, WJ; Meyer-Dudnik, PV; Young, LS1
Ferrieri, P; Johnson, DE; Mitchell, C; Munson, D; Speert, DP; Thompson, TR; Wannamaker, LW1
Belohradsky, BH; Marget, W; Roos, R1
Cookson, B; Leung, T; Tripp, J; Williams, JD1
Gaudry, C; Kourilsky, O1
Aswapokee, N; Chayakul, P; Chuncharunee, S; Leelasuphasri, S; Sathapatayavongs, B; Siritanaratkul, N; Suwangool, P1
Marik, PE1
Beuscart, C; Mouton, YJ1
Sjursen, H; Solberg, CO1
Sleigh, JW1
Castañeda-Hernández, G; Lugo, G2
Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y1
Castañeda-Hernández, G; Lugo-Goytia, G1
Boffa, ML; De Blasi, D; Mastrullo, L; Miraglia, E; Orlando, R; Zorzato, G1
Bourhis, Y; Cerutti, C; Ducher, M; Fauvel, JP; Foltz, F; Jelliffe, R; Maire, P; Sorensen, P1
Jin, D; Wu, H; Wu, Z; Xu, J1
Bal, AM; Ghadage, DP1
Hennemann, HH1
Hasegawa, Y; Masaoka, T; Nakamura, H; Shibata, H; Takubo, T; Ueda, T; Yoshitake, J1
Baughman, KL; Edwards, CQ; Lietman, PS; Rogers, JF; Smith, CR1
Axline, SG; Pesanti, EL; Rhame, FS; Yu, VL1
Greenman, RL; Hoffman, TA; Sklaver, AR1
Bender, JF; Fortner, CL; Hahn, DM; Love, LJ; Schimpff, SC; Standiford, HC; Wiernik, PH; Young, VM1
Hairston, J; Sidell, J; Winston, DJ; Young, LS1
Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M1
Alford, RH; Leonard, JM; McGee, ZA1
Fu, KP; Jahre, JA; Neu, HC1
Caniggia, M; Garabedian, M; Kiegel, P; Lombard, C; Manelli, JC; Palayret, D; Perez-Cappellano, R1
Cartier, F; Cormier, M; Dien, G; Guivarch, G; Hoel, JC1
Berger, SA; Pollock, AA; Rahal, JJ; Richmond, AS; Simberkoff, MS1
Arroyo, JC; Liebhaber, H; Sonnenwirth, AC1
Black, RE; Hewitt, WL; Lau, WK; Linne, SR; Weinstein, RJ; Winston, DJ; Young, LS1
Dupont, C; Hammerberg, S; Marks, MI; Marks, S1
Hensgens, C; Klastersky, J; Meunier-Carpentier, F1
Agre, K; Berman, E; Gooding, PG; Lane, AZ1
Berger, J; Cates, CY; Fox, LM; Gurwith, MJ; Lank, BA; Mathias, RG; McCullough, DW; Ronald, AR; Stiver, HG1
Marget, W; Reindke, B; Versmold, H1
Guerrant, RL; Hamory, BH; Sande, MA; Strausbaugh, LJ; Wenzel, RP1
Finegold, SM; Lewis, RP; Meyer, RD1
Gorbach, SL; Tally, FP2
Seneca, H1
Kobayashi, Y; Shigeta, Y; Tomioka, H1
Dawkins, EJ; Geheber, CE; Kolb, LD; Stone, HH1
Becerra-Munoz, E; Bravo-Scandoval, J; Cinco-Espinoza, G; Flores-Mercado, F; Galindo-Hernandez, E; Ramirez-Jiménez, D1
Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M1
Bartlett, JG; Gorbach, SL; Louie, TJ; O'Keefe, P; Tally, FP1
Matsumoto, F; Saigusa, M; Saito, A; Ueda, Y1
Daschner, F; Senska-Euringer, C1
Carmalt, ED; Finegold, SM; Lewis, RP; Meyer, RD1
Ajarim, DS; al Mohareb, F; al Momen, AK; Harakati, MS; Santhosh-Kumar, CR; Zeitany, RG1
Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT1
Bialkowska-Hobrzanska, H; Gopaul, D; Hammerberg, O1
Bagot, M; Brun-Buisson, C; Chosidow, O; Fraitag, S; Girard-Pipau, F; Revuz, J; Roujeau, JC; Wolkenstein, P1
Gedikoğlu, S; Göral, G; Helvaci, S; Kiliçturgay, K1
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP1
Rong, XZ1
Binder, L; Breitfellner, G; Mittermayer, H; Riezinger, F; Rotter, M; Thiel, W; Watschinger, R1
Bazin, C; Deboscker, Y; Fourrier, F; Moulront, S; Mouton, Y; Philippon, A; Socolovsky, C; Suinat, JL; Tondriaux, A1
Amadori, S; Martino, P; Micozzi, A; Pulsoni, A; Tirindelli, C; Venditti, M1
Aversa, F; Bucaneve, G; Del Favero, A; Fiorio, M; Menichetti, F1
Aoun, M; Bron, D; Meunier, F; Van der Auwera, P1
Howell, AW; Jorgensen, JH; Longfield, RN; Smith, CE; Tillman, BS1
Emanuelsson, BM; Isaksson, B; Maller, R; Nilsson, L1
De Pauw, B; Donnelly, P; Nováková, I1
Adland-Davenport, P; Brown, MP; Derendorf, HC; Robinson, JD1
Al-Shab, T; Lubani, MM; Sethi, S; Sharda, DC1
Hammerberg, O; Kurnitzki, C; Rosenbloom, D; Watts, J1
Albanese, J; Brunel, MF; Durbec, O; Granthil, C; Soula, F1
Baker, CJ; Kaplan, SL; Mason, EO; Parisi, JT; Patrick, CC1
Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M1
Inderlied, CB; Kolonoski, PT; Wu, M; Young, LS1
Calandra, T; Gaya, H; Glauser, MP; Klastersky, J; Meunier, F; Zinner, SH1
Aversa, F; Baldelli, F; Bucaneve, G; Davis, S; Del Favero, A; Guerciolini, R; Menichetti, F; Pauluzzi, S; Terenzi, A1
Aversa, F; Baldelli, F; Bucaneve, G; Del Favero, A; Felicini, R; Menichetti, F; Pauluzzi, S; Terenzi, A1
Munro, R; Rawlinson, W; Sorrell, T1
McCracken, GH; Odio, CM; Saenz, A; Salas, JL; Umana, MA1
Mylotte, JM1
Auboyer, C; Becq-Giraudon, B; Bertrand, P; Buré, A; Carbon, C; Gallais, H; Motin, JP; Mouton, Y; Vachon, F; Wasmer, JM1
Croydon, E; Weerts, D1
Claveau, S; Joly, JR; Lapointe, R; Poirier, A1
Alexopoulos, E; Anassis, P; Hadjidimitriou, C; Papadimitriou, M1
Gaya, H; Glauser, MP; Klastersky, J; Schimpff, SC; Zinner, SH1
Bonetti, A; Luthy, R; Siegenthaler, WE1
Chadwick, EG; Shulman, ST; Yogev, R1
Johnson, DE; Thompson, B1
Klastersky, J; Lagast, H; Meunier, F; Snoeck, R; Woussen, F1
Bru, JP; Hollard, D; Leautet, JB; Legrand, C; Michallet, M; Micoud, M; Sotto, JJ; Stahl, JP; Swierz, P1
Arredondo-García, JL; Calderón-Jaimes, E; Conde-González, C; Echániz-Avilés, G; Reyes-Bolio, JM; Solórzano-Santos, F1
Baird, B; Fauci, AS; Gill, V; Grimes, G; Lane, HC; Masur, H; Tuazon, C1
Bouanchaud, DH; Rolin, O1
Polis, MA; Tuazon, CU1
Cafferkey, MT; Hone, R; Keane, CT1
Mandelli, F; Martino, P; Serra, P; Valente, B; Venditti, M1
Calia, FM; Johnson, DE; Thompson, B1
Carson, CC; Paulson, DF; Rudd, C1
Maslow, MJ; Rahal, JJ; Simberkoff, MS1
Du, JZ; Jiang, YF; Liu, YH; Luo, MY; Qiu, ZD; Sheng, JQ; Wang, QN1
Barton, LL; Fong, CT; Lustig, RH; Walentik, CA1
Lee, CH; Lee, N; Tsai, WC; Wu, JL1
Asada, H; Ito, A; Maruta, I; Matsuzaki, M; Ogawa, K1
Artigas, A; Brunelli, L; Ferrer, R; Goma, G; Navas, A; Pastorelli, R; Ribas Ripoll, V; Romay, E1

Reviews

2 review(s) available for amikacin and Blood Poisoning

ArticleYear
Neonatal osteofibrous dysplasia associated with pathological tibia fracture: a case report and review of the literature.
    Journal of pediatric orthopedics. Part B, 2012, Volume: 21, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Casts, Surgical; Cefotaxime; Clindamycin; Fibrous Dysplasia of Bone; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Sepsis; Tibia; Tibial Fractures; Treatment Outcome

2012
Aminoglycoside antibiotics in infectious diseases. An overview.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kanamycin; Kinetics; Neomycin; Netilmicin; Pneumonia; Sepsis; Sisomicin; Streptomycin; Tobramycin

1986

Trials

51 trial(s) available for amikacin and Blood Poisoning

ArticleYear
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.
    European journal of drug metabolism and pharmacokinetics, 2021, Volume: 46, Issue:5

    Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Prospective Studies; Sepsis; Shock, Septic; Tissue Distribution

2021
Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:3

    Topics: Adult; Amikacin; Anti-Bacterial Agents; APACHE; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Gram-Negative Bacterial Infections; Hemodynamics; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Sepsis; Severity of Illness Index; Tissue Distribution

2013
Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Ear Diseases; Female; Gentamicins; Hearing; Hearing Tests; Humans; Indonesia; Infant; Infant, Newborn; Male; Otoacoustic Emissions, Spontaneous; Risk Factors; Sepsis; Tandem Mass Spectrometry

2013
Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.
    Journal of tropical pediatrics, 2014, Volume: 60, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cloxacillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Hospitals, Teaching; Humans; India; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Length of Stay; Male; Outcome Assessment, Health Care; Sepsis; Single-Blind Method; Time Factors

2014
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
    Journal of tropical pediatrics, 2014, Volume: 60, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome

2014
[In the search for effective and safe dose of amikacin in patients with chronic kidney disease].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2014, Volume: 36, Issue:214

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Insufficiency, Chronic; Sepsis; Treatment Outcome; Urinary Tract Infections; Urine

2014
Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.
    European journal of pediatrics, 2015, Volume: 174, Issue:2

    Topics: Amikacin; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Meconium; Meconium Aspiration Syndrome; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Prospective Studies; Sepsis

2015
Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Acta medica Iranica, 2014, Volume: 52, Issue:9

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Sepsis; Single-Blind Method

2014
The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1

    Topics: Acetylglucosaminidase; Amikacin; Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; Female; Half-Life; Humans; Infant, Newborn; Male; Metabolic Clearance Rate; Renal Insufficiency; Sepsis

2011
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:2

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Creatinine; Female; Humans; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Plasma; Sepsis

2011
Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial.
    Acta medica Iranica, 2011, Volume: 49, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Ceftizoxime; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Sepsis

2011
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
    Clinical biochemistry, 2012, Volume: 45, Issue:10-11

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome

2012
Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate.
    The Journal of urology, 2013, Volume: 189, Issue:3

    Topics: Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prostate; Rectum; Sepsis; Treatment Outcome

2013
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
    Archives of surgery (Chicago, Ill. : 1960), 2006, Volume: 141, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Peritonitis; Recombinant Proteins; Sepsis; Survival Rate; Treatment Outcome

2006
Management of diabetic foot in a Jordanian hospital.
    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2005, Volume: 11, Issue:3

    Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection

2005
Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime.
    American journal of perinatology, 2007, Volume: 24, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta 2-Microglobulin; Creatine; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidney; Sepsis

2007
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:6

    Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Sepsis; Time Factors

2007
Early granulocyte transfusions in high risk febrile neutropenic patients.
    Schweizerische medizinische Wochenschrift. Supplementum, 1983, Volume: 14

    Topics: Agranulocytosis; Amikacin; Blood Transfusion; Carbenicillin; Clinical Trials as Topic; Gram-Negative Bacteria; Granulocytes; Humans; Neutropenia; Risk; Sepsis

1983
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections

1984
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
    The Journal of infectious diseases, 1984, Volume: 149, Issue:1

    Topics: Amikacin; Body Temperature; Female; Gentamicins; Hearing Loss; Humans; Kanamycin; Male; Probability; Risk; Sepsis; Statistics as Topic; Time Factors; Tobramycin

1984
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:2

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Lung Diseases; Male; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections

1980
Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl A

    Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Humans; Netilmicin; Neutropenia; Sepsis

1981
Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1993, Volume: 76, Issue:6

    Topics: Adolescent; Adult; Aged; Amikacin; Ceftriaxone; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Sepsis

1993
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A

    Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections

1995
Safety and efficacy of meropenem in patients with septicaemia: a randomised comparison with ceftazidime, alone or combined with amikacin.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A

    Topics: Adult; Aged; Amikacin; Carbapenems; Ceftazidime; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Sepsis; Thienamycins; Treatment Outcome

1995
Amikacin Bayesian forecasting in critically ill patients with sepsis and cirrhosis.
    Therapeutic drug monitoring, 1997, Volume: 19, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Bayes Theorem; Critical Illness; Humans; Liver Cirrhosis; Middle Aged; Sepsis

1997
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis

2000
Controlled comparison of amikacin and gentamicin.
    The New England journal of medicine, 1977, Feb-17, Volume: 296, Issue:7

    Topics: Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney; Middle Aged; Prospective Studies; Sepsis; Urinary Tract Infections

1977
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
    The American journal of medicine, 1979, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Infections; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin

1979
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    The Journal of infectious diseases, 1977, Volume: 135, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections

1977
Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
    The American journal of medicine, 1977, Volume: 62, Issue:6

    Topics: Adult; Amikacin; Bacterial Infections; Carbenicillin; Drug Synergism; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Leukopenia; Penicillin Resistance; Sepsis

1977
Evaluation of three antibiotic programs in newborn infants.
    Canadian Medical Association journal, 1978, Mar-18, Volume: 118, Issue:6

    Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bilirubin; Cephalothin; Drug Therapy, Combination; Evaluation Studies as Topic; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pneumonia; Sepsis; Tobramycin

1978
Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Amikacin; Bacterial Infections; Blood Bactericidal Activity; Carbenicillin; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Penicillin G; Pseudomonas Infections; Sepsis

1976
A review of results of clinical trials with amikacin.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bone Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections

1976
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination

1992
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In
    The Journal of infectious diseases, 1991, Volume: 163, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin

1991
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
    Presse medicale (Paris, France : 1983), 1990, Apr-04, Volume: 19, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sepsis

1990
Gram-positive bacteraemia in granulocytopenic cancer patients.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5

    Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis

1990
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    British journal of haematology, 1990, Volume: 76 Suppl 2

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Sepsis; Teicoplanin

1990
Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.
    British journal of haematology, 1990, Volume: 76 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Glycopeptides; Humans; Leukemia; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Teicoplanin

1990
Amikacin once daily: a new dosing regimen based on drug pharmacokinetics.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:5

    Topics: Aged; Amikacin; Creatinine; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Sepsis

1990
Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Aspergillosis; Aspergillus fumigatus; Ceftazidime; Cell Count; Drug Therapy, Combination; Female; Fever; Humans; Male; Piperacillin; Sepsis

1990
Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:3

    Topics: Amikacin; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Piperacillin; Random Allocation; Risk Factors; Sepsis

1989
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
    Pathologie-biologie, 1989, Volume: 37, Issue:5

    Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis

1989
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
    The New England journal of medicine, 1987, 12-31, Volume: 317, Issue:27

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Ceftazidime; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation; Regression Analysis; Sepsis

1987
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7

    Topics: Acute Disease; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacteria; Humans; Leukemia; Prospective Studies; Random Allocation; Sepsis; Teicoplanin

1987
Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Amikacin; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis

1987
European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; beta-Lactamase Inhibitors; Child; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Netilmicin; Neutropenia; Penicillins; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin

1987
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Cefotaxime; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Male; Middle Aged; Penicillins; Prospective Studies; Random Allocation; Regression Analysis; Sepsis; Ticarcillin

1986
A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl C

    Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Penicillin Resistance; Penicillins; Prospective Studies; Random Allocation; Sepsis; Ticarcillin

1986
Laboratory and clinical studies on amikacin.
    Chinese medical journal, 1985, Volume: 98, Issue:11

    Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Kanamycin; Pyelonephritis; Sepsis; Staphylococcus aureus

1985

Other Studies

151 other study(ies) available for amikacin and Blood Poisoning

ArticleYear
Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.
    European journal of hospital pharmacy : science and practice, 2022, Volume: 29, Issue:e1

    Topics: Amikacin; Anti-Bacterial Agents; Critical Illness; Humans; Multiple Organ Failure; Sepsis

2022
Congenital brucellosis associated with subsequent Klebsiella pneumoniae co-infection in a premature neonate: A rare case report.
    Journal of infection and public health, 2022, Volume: 15, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Coinfection; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Respiratory Distress Syndrome; Rifampin; Sepsis

2022
Amikacin Monotherapy for Peripherally Inserted Central Catheter-Related Bloodstream Infection due to Tsukamurella pulmonis.
    American journal of therapeutics, 2022, 07-01, Volume: 29, Issue:4

    Topics: Actinobacteria; Amikacin; Catheter-Related Infections; Catheterization, Central Venous; Catheterization, Peripheral; Catheters; Humans; Risk Factors; Sepsis

2022
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
    Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis

2022
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
    The Pan African medical journal, 2022, Volume: 42

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania

2022
In vitro antibacterial activity and in vivo pharmacokinetics of intravenously administered Amikacin-loaded Liposomes for the management of bacterial septicaemia.
    Colloids and surfaces. B, Biointerfaces, 2022, Volume: 220

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Liposomes; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Sepsis; Staphylococcal Infections; Staphylococcus aureus

2022
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
    Cellular and molecular biology (Noisy-le-Grand, France), 2022, Jun-30, Volume: 68, Issue:6

    Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Whole genome sequencing of OXA-232-producing
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprofloxacin; DNA Transposable Elements; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis; Virulence; Virulence Factors; Whole Genome Sequencing

2022
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis.
    Journal of chemotherapy (Florence, Italy), 2023, Volume: 35, Issue:6

    Topics: Acute Kidney Injury; Amikacin; Colistin; Critical Illness; Humans; Intensive Care Units; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic

2023
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
    Clinical laboratory, 2023, Jan-01, Volume: 69, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin

2023
Population pharmacokinetics of amikacin in suspected cases of neonatal sepsis.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant, Newborn; Metabolic Clearance Rate; Neonatal Sepsis; Sepsis

2023
Therapeutic drug monitoring of amikacin in preterm and term neonates with late-onset sepsis. Can saliva samples replace plasma samples?
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:10

    Topics: Amikacin; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Infant, Newborn; Premature Birth; Prospective Studies; Saliva; Sepsis

2023
Evaluation of Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Glomerular Filtration Rate and Amikacin Clearance During Early Rat Endotoxemia: Comparison with Traditional Endogenous and Exogenous Biomarkers.
    European journal of drug metabolism and pharmacokinetics, 2020, Volume: 45, Issue:1

    Topics: Acute Kidney Injury; Amikacin; Animals; Biomarkers; Cytokines; Endotoxemia; Glomerular Filtration Rate; Inflammation; Kidney; Lipocalin-2; Lipopolysaccharides; Male; Metabolic Clearance Rate; Models, Animal; Oligosaccharides; Predictive Value of Tests; Rats; Rats, Wistar; Sepsis; Urine

2020
Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Asphyxia; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hypothermia, Induced; Infant, Newborn; Monte Carlo Method; Obstetric Labor Complications; Parturition; Pregnancy; Sepsis

2017
Optimal Amikacin Levels for Patients with Sepsis in Intensive Care Unit of Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Acta medica Indonesiana, 2017, Volume: 49, Issue:3

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cross-Sectional Studies; Dose-Response Relationship, Drug; Escherichia coli; Female; Humans; Indonesia; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Sepsis; Young Adult

2017
[Antimicrobial susceptibility of bacteria causing urosepsis].
    Revista medica de Chile, 2017, Volume: 145, Issue:6

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Blood Culture; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Ureterolithiasis; Urinary Tract Infections; Young Adult

2017
Myocardial calcifications following sepsis.
    Intensive care medicine, 2018, Volume: 44, Issue:6

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Calcinosis; Cardiomyopathies; Cefotaxime; Female; Humans; Norepinephrine; Sepsis; Treatment Outcome; Vasoconstrictor Agents

2018
Initial antimicrobial treatment of foals with sepsis: Do our choices make a difference?
    Veterinary journal (London, England : 1997), 2019, Volume: 243

    Topics: Amikacin; Ampicillin; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Horse Diseases; Horses; Retrospective Studies; Sepsis

2019
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
    Anaesthesia, critical care & pain medicine, 2019, Volume: 38, Issue:5

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin

2019
Nocardial endocarditis in native aortic valve with nocardial sepsis in a case of breast cancer.
    BMJ case reports, 2019, Jul-11, Volume: 12, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Anticoagulants; Aortic Valve; Breast Neoplasms; Central Venous Catheters; Clopidogrel; Cough; Endocarditis, Bacterial; Fatigue; Female; Headache; Heart Valve Prosthesis Implantation; Humans; Meropenem; Middle Aged; Nocardia; Nocardia Infections; Platelet Aggregation Inhibitors; Radiography, Thoracic; Sepsis; Treatment Outcome; Warfarin

2019
Re: Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: E. O. Kehinde, M. Al-maghrebi, M. Sheikh and J. T. Anim J Urol 2013, 189: 911-915.
    The Journal of urology, 2013, Volume: 190, Issue:4

    Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis

2013
Amikacin population pharmacokinetics among paediatric burn patients.
    Burns : journal of the International Society for Burn Injuries, 2014, Volume: 40, Issue:2

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin

2014
Therapeutic drug monitoring of amikacin in septic patients.
    Critical care (London, England), 2013, Jul-25, Volume: 17, Issue:4

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Sepsis

2013
Reply by authors.
    The Journal of urology, 2013, Volume: 190, Issue:4

    Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis

2013
Aminoglycosides and ototoxicity in neonates: is there a relation with serum concentrations?
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Ear Diseases; Female; Gentamicins; Hearing; Humans; Male; Sepsis

2013
Reply by authors.
    The Journal of urology, 2014, Volume: 191, Issue:3

    Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis

2014
Re: combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate: O. Kehinde, M. Al-Maghrebi, M. Sheikh and J. T. Anim J Urol 2013; 189: 911–915.
    The Journal of urology, 2014, Volume: 191, Issue:3

    Topics: Amikacin; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Endosonography; Humans; Male; Prostate; Sepsis

2014
Cerebral abscess due to Serratia marcescens.
    Indian journal of pediatrics, 2015, Volume: 82, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Drainage; Frontal Lobe; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Long Term Adverse Effects; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Serratia marcescens; Tomography, X-Ray Computed; Treatment Outcome

2015
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
    The new microbiologica, 2015, Volume: 38, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline

2015
Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoring.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:10

    Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Female; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Thienamycins

2015
Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Amikacin; Anti-Bacterial Agents; Birth Weight; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Models, Statistical; Monte Carlo Method; Precision Medicine; Prospective Studies; Sepsis

2015
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Female; France; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Serum; Young Adult

2016
Neonatal Conjunctivitis Leading to Neonatal Sepsis--A Case Report.
    Mymensingh medical journal : MMJ, 2016, Volume: 25, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Conjunctivitis; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Male; Meropenem; Sepsis; Thienamycins; Treatment Outcome

2016
Netilmicin withdrawal: impact on neonates.
    The New Zealand medical journal, 2008, Oct-17, Volume: 121, Issue:1284

    Topics: Amikacin; Anti-Bacterial Agents; Drug and Narcotic Control; Humans; Infant, Newborn; Medical Audit; Netilmicin; New Zealand; Retrospective Studies; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Treatment Failure

2008
[Case of sepsis caused by multidrug-resistant neutropenic-phase Pseudomonas aeruginosa treated successfully with antibiotic combination therapy].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Treatment Outcome

2008
Inadequate timing between corticosteroid and antibiotics applications increases mortality due to sepsis.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Glucocorticoids; Klebsiella Infections; Male; Methylprednisolone; Mice; Sepsis; Staphylococcal Infections; Teicoplanin

2008
Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Menstruation; Metabolic Clearance Rate; Models, Biological; Reproducibility of Results; Risk Factors; Sepsis; Time Factors; Treatment Failure

2009
[Cost of therapeutic failure of ampicillin plus amikacin in the treatment of early neonatal sepsis].
    Anales de pediatria (Barcelona, Spain : 2003), 2009, Volume: 71, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Costs and Cost Analysis; Decision Trees; Drug Therapy, Combination; Humans; Infant, Newborn; Sepsis; Time Factors; Treatment Failure

2009
Therapeutic drug monitoring of amikacin in preterm and term infants.
    Singapore medical journal, 2009, Volume: 50, Issue:5

    Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Risk Factors; Sepsis

2009
Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
    Clinical biochemistry, 2010, Volume: 43, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Calibration; Critical Illness; Drug Dosage Calculations; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Empirical Research; Female; Humans; Male; Middle Aged; Models, Theoretical; Sepsis; Young Adult

2010
Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Aged; Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Creatinine; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Sepsis

2010
Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Therapeutic drug monitoring, 2010, Volume: 32, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Illness; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Sepsis; Tissue Distribution

2010
Optimising amikacin regimens in septic patients.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Plasma; Sepsis

2012
[Neonatal infection with Stenotrophomonas maltophilia (2 case studies)].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2012, Volume: 19, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echoencephalography; Empyema, Subdural; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sepsis; Stenotrophomonas maltophilia; Thiamphenicol; Tomography, X-Ray Computed

2012
Facial ecthyma gangrenosum in 2 preterm neonates.
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7

    Topics: Amikacin; Facial Dermatoses; Fatal Outcome; Female; Gangrene; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meropenem; Necrosis; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial; Skin Ulcer; Thienamycins

2012
Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome.
    BMC public health, 2012, Oct-24, Volume: 12

    Topics: Amikacin; Ampicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cloxacillin; Escherichia coli; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella; Male; Microbial Sensitivity Tests; Sepsis; Staphylococcus aureus; Tanzania; Treatment Outcome

2012
Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia.
    Journal of clinical pharmacy and therapeutics, 2003, Volume: 28, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Incidence; Infant, Newborn; Retrospective Studies; Saudi Arabia; Sepsis; Vancomycin

2003
Neonatal sepsis and meningitis in Haiti.
    Journal of tropical pediatrics, 2004, Volume: 50, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Enterobacter aerogenes; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Haiti; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Prospective Studies; Sepsis

2004
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39 Suppl 1

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis

2004
n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: alpha-Linolenic Acid; Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fatty Acids, Unsaturated; Lipopolysaccharides; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis; Tumor Necrosis Factor-alpha

2004
Chromobacterium violaceum septicaemia from north India.
    The Indian journal of medical research, 2004, Volume: 120, Issue:6

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chromobacterium; Ciprofloxacin; Female; Humans; India; Infant; Infant, Newborn; Male; Sepsis

2004
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:2

    Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha

2005
[Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?].
    Revista panamericana de salud publica = Pan American journal of public health, 2004, Volume: 16, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Models, Theoretical; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus

2004
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
    Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:1

    Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha

2005
Antibiotic-induced release of inflammatory mediators from bacteria in experimental Klebsiella pneumoniae-induced sepsis.
    Folia microbiologica, 2005, Volume: 50, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Disease Models, Animal; Endotoxins; Humans; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Sepsis; Tumor Necrosis Factor-alpha

2005
The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
    Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis

2006
Neonatal diarrhea and septicemia in an American Miniature Horse.
    The Veterinary clinics of North America. Equine practice, 2006, Volume: 22, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Blood Cell Count; Blood Chemical Analysis; Dehydration; Diarrhea; Fluid Therapy; Glucose; Horse Diseases; Horses; Hyperemia; Infusions, Intravenous; Male; Penicillins; Sepsis; Sodium Chloride; Sweetening Agents; Urinalysis

2006
Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:4

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Cells, Cultured; Humans; Immunologic Factors; Iridoid Glucosides; Iridoids; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrans; Rabbits; Sepsis; Survival

2006
Chromobacterium violaceum: a case report of an unusual bacterium causing puerperal sepsis.
    Indian journal of pathology & microbiology, 2006, Volume: 49, Issue:3

    Topics: Academic Medical Centers; Adult; Amikacin; Anti-Bacterial Agents; Chromobacterium; Female; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; India; Puerperal Infection; Sepsis

2006
Paratyphoid sepsis.
    Indian journal of pediatrics, 2007, Volume: 74, Issue:2

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Bottle Feeding; Breast Feeding; Cesarean Section; Female; Follow-Up Studies; Humans; India; Infusions, Intravenous; Male; Ofloxacin; Paratyphoid Fever; Pregnancy; Risk Assessment; Salmonella paratyphi A; Sepsis; Treatment Outcome

2007
Are we finally ready for outpatient management of febrile neutropenia?
    Pediatric blood & cancer, 2007, Volume: 49, Issue:6

    Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Monitoring, Physiologic; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Safety Management; Sepsis; Time Factors

2007
[Sepsis caused by pigmented and no pigmented Chromobacterium violaceum].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2007, Volume: 24, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Chromobacterium; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Indians, South American; Infant; Male; Psoas Abscess; Sepsis

2007
Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.
    Croatian medical journal, 2008, Volume: 49, Issue:2

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Croatia; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Longitudinal Studies; Netilmicin; Prospective Studies; Sepsis

2008
[The determination of pharmacokinetic parameters from surveillance protocols of sepsis therapy].
    Der Internist, 1983, Volume: 24, Issue:3

    Topics: Amikacin; Cefoxitin; Computers; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Metabolic Clearance Rate; Penicillin G; Sepsis

1983
Aminoglycoside-related nephrotoxicity in the premature newborn.
    Clinical pharmacology and therapeutics, 1984, Volume: 35, Issue:3

    Topics: Acetylglucosaminidase; Amikacin; beta 2-Microglobulin; Chloramphenicol; Creatinine; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Kanamycin; Kidney Diseases; Prospective Studies; Random Allocation; Sepsis

1984
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:3

    Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin

1980
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
    The Journal of infectious diseases, 1984, Volume: 149, Issue:3

    Topics: Adult; Aged; Amikacin; Body Temperature; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kidney Diseases; Leukocyte Count; Middle Aged; Proteus Infections; Sepsis; Statistics as Topic; Tobramycin

1984
Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
    Medicina, 1981, Volume: 41 Suppl

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cephalothin; Cephapirin; Child; Child, Preschool; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Random Allocation; Sepsis; Tobramycin

1981
Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
    International journal of clinical pharmacology, therapy, and toxicology, 1982, Volume: 20, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1982
Fatal pneumonia. Emergence of an amikacin sulfate-resistant strain of Escherichia coli.
    New York state journal of medicine, 1981, Volume: 81, Issue:7

    Topics: Amikacin; Drug Resistance, Microbial; Escherichia coli; Humans; Kanamycin; Male; Middle Aged; Pneumonia; Sepsis

1981
Amikacin treatment of Serratia septicemia in critically ill patients.
    Critical care medicine, 1981, Volume: 9, Issue:9

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Critical Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Sepsis; Serratia marcescens

1981
Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
    Pharmatherapeutica, 1982, Volume: 3, Issue:2

    Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Rats; Rats, Inbred Strains; Sepsis; Sisomicin; Tobramycin

1982
[Clinical report of an aged patient with lung abscess who show an excellent response after long-term administration of amikacin (author's transl)].
    The Japanese journal of antibiotics, 1982, Volume: 35, Issue:3

    Topics: Aged; Amikacin; Bacteria; Drug Resistance, Microbial; Female; Humans; Kanamycin; Lung Abscess; Sepsis

1982
Bacteremic group G streptococcal pneumonia.
    Southern medical journal, 1982, Volume: 75, Issue:11

    Topics: Amikacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Penicillin G Procaine; Pneumonia; Sepsis; Streptococcal Infections; Streptococcus

1982
Mycobacterium chelonei septicemia in a premature infant.
    The Journal of pediatrics, 1980, Volume: 96, Issue:4

    Topics: Amikacin; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis

1980
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
    Infection, 1980, Volume: Suppl 1

    Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin

1980
Evaluation of amikacin dosage regimes in the low and very low birthweight newborn.
    Infection, 1980, Volume: 8 Suppl 3

    Topics: Amikacin; Dose-Response Relationship, Drug; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male; Sepsis

1980
[Is it possible to save an infected catheter?].
    Nephrologie, 1994, Volume: 15, Issue:2

    Topics: Adult; Amikacin; Anesthesia; Catheterization, Central Venous; Catheters, Indwelling; Drug Resistance, Microbial; Equipment Contamination; Fatal Outcome; Female; Heparin; Humans; Jugular Veins; Pseudomonas; Pseudomonas Infections; Renal Dialysis; Seizures; Sepsis

1994
Aminoglycoside volume of distribution and illness severity in critically ill septic patients.
    Anaesthesia and intensive care, 1993, Volume: 21, Issue:2

    Topics: Adult; Amikacin; Creatinine; Critical Illness; Extracellular Space; Gram-Negative Bacterial Infections; Humans; Sepsis; Severity of Illness Index

1993
Volume distribution of amikacin.
    Intensive care medicine, 1997, Volume: 23, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Computer Simulation; Humans; Kidney; Metabolic Clearance Rate; Models, Biological; Sepsis; Tissue Distribution

1997
Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
    Critical care medicine, 1997, Volume: 25, Issue:5

    Topics: Adult; Amikacin; Anti-Bacterial Agents; APACHE; Critical Care; Cross-Sectional Studies; Female; Gram-Negative Bacterial Infections; Half-Life; Hemodynamics; Humans; Infusion Pumps; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Sepsis

1997
Bayesian approach to control of amikacin serum concentrations in critically ill patients with sepsis.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Bayes Theorem; Critical Care; Critical Illness; Humans; Middle Aged; Models, Statistical; Retrospective Studies; Sepsis

2000
Aeromonas sobria sepsis in a neutropenic patient.
    Haematologica, 2001, Volume: 86, Issue:4

    Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid; Neutropenia; Sepsis

2001
Renal elimination of amikacin and the aging process.
    Clinical pharmacokinetics, 2001, Volume: 40, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Aging; Amikacin; Anti-Bacterial Agents; France; Humans; Kidney; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Probability; Retrospective Studies; Sepsis

2001
[Nosocomial catheter-related sepsis secondary to central venous catheters].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1999, Volume: 37, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin

1999
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
    Japanese journal of infectious diseases, 2002, Volume: 55, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Norfloxacin; Penicillins; Prevalence; Retrospective Studies; Salmonella; Salmonella Infections; Sepsis; Time Factors

2002
[Septicaemia in leukaemia (author's transl)].
    Medizinische Klinik, 1977, Apr-15, Volume: 72, Issue:15

    Topics: Adult; Amikacin; Ampicillin; Chloramphenicol; Female; Gentamicins; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Leukemia; Leukemia, Lymphoid; Mycoses; Sepsis; Staphylococcal Infections; Streptococcal Infections

1977
[Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].
    The Japanese journal of antibiotics, 1977, Volume: 30, Issue:12

    Topics: Adolescent; Adult; Amikacin; Anemia, Aplastic; Female; Hematologic Diseases; Humans; Infections; Injections, Intravenous; Kanamycin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Sepsis

1977
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    JAMA, 1977, Aug-29, Volume: 238, Issue:9

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Ear; Gentamicins; Humans; Kanamycin; Middle Aged; Pseudomonas; Sepsis; Serratia marcescens; Tobramycin

1977
Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Archives of internal medicine, 1978, Volume: 138, Issue:5

    Topics: Adolescent; Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Kanamycin; Klebsiella Infections; Meningitis; Proteus Infections; Sepsis; Serratia marcescens

1978
Antimicrobial therapy of septicemia due to Klebsiella pneumoniae in neutropenic rats.
    The Journal of infectious diseases, 1979, Volume: 139, Issue:4

    Topics: Agranulocytosis; Amikacin; Animals; Cefazolin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neutropenia; Rats; Sepsis

1979
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Archives of internal medicine, 1978, Volume: 138, Issue:2

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections

1978
Clinical evaluation of netilmicin therapy in serious infections.
    The American journal of medicine, 1979, Volume: 66, Issue:1

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections

1979
[Clinical and pharmacokinetic study of amikacin in septicemia complicating major burns].
    La Nouvelle presse medicale, 1979, Oct-31, Volume: 8, Issue:42

    Topics: Adolescent; Adult; Aged; Amikacin; Burns; Humans; Kanamycin; Kinetics; Microbial Sensitivity Tests; Middle Aged; Sepsis

1979
[Amikacin in the treatment of Gram negative bacilli septicemias].
    La Nouvelle presse medicale, 1979, Oct-31, Volume: 8, Issue:42

    Topics: Amikacin; Critical Care; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Sepsis; Tobramycin

1979
Amikacin therapy for serious gram-negative infection.
    JAMA, 1977, Feb-07, Volume: 237, Issue:6

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Kanamycin; Kidney; Klebsiella Infections; Middle Aged; Pseudomonas Infections; Sepsis

1977
Proteus rettgeri infections: a review.
    The Journal of urology, 1977, Volume: 117, Issue:1

    Topics: Adolescent; Amikacin; Gentamicins; Humans; Male; Penicillin Resistance; Penicillins; Proteus Infections; Quadriplegia; Sepsis

1977
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections

1976
Use of Amikacin in a hospital for children: microbiological and clinical studies.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Kanamycin; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections

1976
Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.
    The American journal of medicine, 1977, Volume: 62, Issue:6

    Topics: Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Female; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis

1977
Amikacin therapy for gram-negative septicemia.
    The American journal of medicine, 1977, Volume: 62, Issue:6

    Topics: Adult; Aged; Amikacin; Creatinine; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Sepsis

1977
Amikacin therapy of gram-negative bacteremia.
    The American journal of medicine, 1977, Volume: 62, Issue:6

    Topics: Amikacin; Gentamicins; Hearing Disorders; Humans; Kanamycin; Sepsis

1977
Review of 152 patients with bacteremias treated with amikacin.
    The American journal of medicine, 1977, Volume: 62, Issue:6

    Topics: Adult; Aged; Amikacin; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Middle Aged; Sepsis

1977
Gram-negative sepsis: part II. Management.
    Comprehensive therapy, 1977, Volume: 3, Issue:8

    Topics: Acidosis; Adult; Amikacin; Child; Chloramphenicol; Clindamycin; Disseminated Intravascular Coagulation; Dopamine; Gentamicins; Heart Failure; Humans; Isoproterenol; Kanamycin; Kidney Diseases; Metaraminol; Phenoxybenzamine; Respiratory Insufficiency; Sepsis; Tobramycin

1977
[Therapeutic experience of Proteus morganii septicemia with amikacin (author's transl)].
    The Japanese journal of antibiotics, 1977, Volume: 30, Issue:8

    Topics: Amikacin; Humans; Intracranial Aneurysm; Kanamycin; Male; Middle Aged; Proteus Infections; Sepsis

1977
Use of aminoglycosides in surgical infections.
    Annals of surgery, 1976, Volume: 183, Issue:6

    Topics: Abscess; Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Male; Middle Aged; Peritonitis; Sepsis; Sisomicin; Surgical Wound Infection; Tobramycin; Wound Infection

1976
Amikacin.
    The Medical letter on drugs and therapeutics, 1976, Nov-05, Volume: 18, Issue:23

    Topics: Amikacin; Bacteria; Drug Resistance, Microbial; Humans; Infant, Newborn; Kanamycin; Sepsis

1976
Amikacin for treatment of septic abortions: summary.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Abortion, Septic; Amikacin; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Pregnancy; Sepsis

1976
Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections

1976
Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    The Journal of infectious diseases, 1976, Volume: 134 SUPPL

    Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Sepsis

1976
[A case of E. coli septicemia successfully treated with amikacin (author's transl)].
    The Japanese journal of antibiotics, 1975, Volume: 28, Issue:5

    Topics: Amikacin; Carbenicillin; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Sepsis

1975
[Contaminated infusions as cause of nosocomial Serratia marcescens septicaemia in children (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1975, Nov-07, Volume: 100, Issue:45

    Topics: Age Factors; Amikacin; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Nalidixic Acid; Sepsis; Serratia marcescens

1975
Amikacin therapy for serious gram-negative bacillary infections.
    Annals of internal medicine, 1975, Volume: 83, Issue:6

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Ear, Inner; Female; Humans; Kanamycin; Kidney; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections

1975
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
    The Journal of infection, 1992, Volume: 25, Issue:1

    Topics: Adult; Amikacin; Ceftazidime; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Mycoses; Neoplasms; Neutropenia; Saudi Arabia; Sepsis; Treatment Outcome

1992
Isolation of Agrobacterium radiobacter from a central venous catheter.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:5

    Topics: Amikacin; Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Piperacillin; Rhizobium; Sepsis

1991
Nocardia asteroides septicemia in a pemphigus patient. Successful treatment with trimethoprim-sulfamethoxazole and amikacin association.
    Dermatologica, 1990, Volume: 181, Issue:4

    Topics: Amikacin; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Middle Aged; Nocardia asteroides; Nocardia Infections; Pemphigus; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination

1990
[Salmonella typhimurium infections in the area of Bursa].
    Mikrobiyoloji bulteni, 1990, Volume: 24, Issue:2

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Salmonella Infections; Salmonella typhimurium; Sepsis; Turkey

1990
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:4

    Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin

1990
[Experimental study of pulmonary infection and its systemic dissemination in the early stage of severe burn].
    Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns, 1990, Volume: 6, Issue:1

    Topics: Amikacin; Animals; Burns; Disease Susceptibility; Endotoxins; Female; Male; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis

1990
Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1990, Volume: 272, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Austria; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Pseudomonas aeruginosa; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Tobramycin

1990
Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    British journal of haematology, 1990, Volume: 76 Suppl 2

    Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bone Marrow Transplantation; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Leukemia; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Sepsis; Teicoplanin

1990
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6

    Topics: Adult; Amikacin; beta-Lactamases; Blotting, Southern; Ceftazidime; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Microbial Sensitivity Tests; Sepsis; Wounds and Injuries

1990
Pharmacokinetics of amikacin in critically ill neonatal foals treated for presumed or confirmed sepsis.
    Equine veterinary journal, 1990, Volume: 22, Issue:1

    Topics: Amikacin; Animals; Animals, Newborn; Horse Diseases; Horses; Immunization, Passive; Least-Squares Analysis; Pneumonia; Sepsis

1990
Neonatal listeriosis: a report of seven cases.
    Annals of tropical paediatrics, 1987, Volume: 7, Issue:1

    Topics: Amikacin; Ampicillin; Cerebrospinal Fluid; Disease Outbreaks; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Kuwait; Listeriosis; Male; Meningitis, Listeria; Sepsis

1987
[Fulminating Pseudomonas maltophilia septicemia during treatment with imipenem and amikacin].
    Presse medicale (Paris, France : 1983), 1989, Feb-11, Volume: 18, Issue:5

    Topics: Amikacin; Drug Resistance, Microbial; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Sepsis

1989
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates.
    Pediatrics, 1989, Volume: 84, Issue:6

    Topics: Amikacin; Bacteriophage Typing; Coagulase; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Methicillin; Sepsis; Species Specificity; Staphylococcal Infections; Staphylococcus; Vancomycin

1989
Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Female; Imipenem; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organ Size; Sepsis

1989
Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 21 Suppl A

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftazidime; Child; Drug Therapy, Combination; Female; Glycopeptides; Humans; Male; Middle Aged; Postoperative Complications; Sepsis; Teicoplanin

1988
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
    Australian and New Zealand journal of medicine, 1988, Volume: 18, Issue:6

    Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin

1988
Treatment of gram-negative bacteremia in patients with cancer and granulocytopenia.
    The New England journal of medicine, 1988, Jun-23, Volume: 318, Issue:25

    Topics: Agranulocytosis; Amikacin; Ceftazidime; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Neoplasms; Sepsis

1988
Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia.
    The Pediatric infectious disease journal, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Bacteria; Blood Bactericidal Activity; Carbenicillin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Penicillin Resistance; Recurrence; Sepsis

1987
Gentamicin resistance among gram-negative bacillary blood isolates in a hospital with long-term use of gentamicin.
    Archives of internal medicine, 1987, Volume: 147, Issue:9

    Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Proteus mirabilis; Sepsis; Serratia marcescens

1987
In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacteriuria; Drug Resistance, Microbial; Escherichia coli; Europe; Gentamicins; Humans; Netilmicin; Pseudomonas; Sepsis; Staphylococcus; Tobramycin

1987
Bacteremia caused by Pseudomonas mesophilica.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1988, Sep-01, Volume: 139, Issue:5

    Topics: Amikacin; Catheterization, Central Venous; Catheters, Indwelling; Humans; Male; Middle Aged; Pseudomonas Infections; Sepsis

1988
The efficacy of amikacin in the treatment of severe infections in a renal unit.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Amikacin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Hospital Units; Humans; Kidney Diseases; Male; Middle Aged; Penicillins; Sepsis

1987
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    The Journal of infectious diseases, 1986, Volume: 154, Issue:4

    Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins

1986
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C

    Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin

1986
Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl C

    Topics: Adult; Aged; Agranulocytosis; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin

1986
[Neonatal septicemia caused by Staphylococcus epidermidis].
    Boletin medico del Hospital Infantil de Mexico, 1987, Volume: 44, Issue:9

    Topics: Amikacin; Ampicillin; Dicloxacillin; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis

1987
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cycloserine; Drug Therapy, Combination; Humans; Isoniazid; Lactams, Macrocyclic; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis

1987
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
    Drugs under experimental and clinical research, 1986, Volume: 12, Issue:11

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin

1986
Clues to the early diagnosis of Mycobacterium avium-intracellulare infection in patients with acquired immunodeficiency syndrome.
    Archives of pathology & laboratory medicine, 1985, Volume: 109, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Clofazimine; Female; Humans; Lactams, Macrocyclic; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis

1985
Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6

    Topics: Adult; Aged; Amikacin; Drug Combinations; Female; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

1985
Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemia.
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:4

    Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Combinations; Drug Synergism; Gram-Negative Bacteria; Humans; Kanamycin; Leukemia; Microbial Sensitivity Tests; Penicillins; Sepsis; Ticarcillin

1985
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis

1985
Overview of first-line amikacin therapy for urologic infections.
    The American journal of medicine, 1985, Jul-15, Volume: 79, Issue:1A

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Kidney Diseases; Lactams; Sepsis; Urinary Tract Infections

1985
Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:2

    Topics: Aged; Amikacin; Aminoglycosides; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens

1985
Neonatal septicemia due to Pseudomonas aeruginosa.
    American family physician, 1986, Volume: 33, Issue:3

    Topics: Adult; Amikacin; Ampicillin; Female; Humans; Infant, Newborn; Kanamycin; Male; Pregnancy; Pseudomonas Infections; Sepsis; Ticarcillin

1986
Pseudomonas pseudomallei infection from drowning: the first reported case in Taiwan.
    Journal of clinical microbiology, 1985, Volume: 22, Issue:3

    Topics: Amikacin; Bronchopneumonia; Cephalothin; Drowning; Drug Therapy, Combination; Female; Humans; Melioidosis; Middle Aged; Pseudomonas; Sepsis; Taiwan; Water Microbiology

1985
[Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
    The Japanese journal of antibiotics, 1985, Volume: 38, Issue:8

    Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Bacterial Infections; Cystitis; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sepsis

1985
Metabolite analysis in sepsis through conditional independence maps.
    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2015, Volume: 2015

    Topics: Adult; Aged; Algorithms; Bayes Theorem; Biomarkers; Carnitine; Computer Graphics; Critical Care; Female; Humans; Intensive Care Units; Isoleucine; Length of Stay; Male; Markov Chains; Metabolomics; Middle Aged; Models, Statistical; Patient Discharge; Probability; Prospective Studies; Sepsis; Shock, Septic

2015